Cargando…
Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
BACKGROUND: Resistance to oxaliplatin is a major obstacle for the management of locally advanced and metastatic colon cancer (CC). Although long noncoding RNAs (lncRNAs) play key roles in CC, the relationships between lncRNAs and resistance to oxaliplatin have been poorly understood yet. METHODS: Ch...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570024/ https://www.ncbi.nlm.nih.gov/pubmed/34740372 http://dx.doi.org/10.1186/s13046-021-02143-x |
_version_ | 1784594759675805696 |
---|---|
author | Li, Qingguo Sun, Huizhen Luo, Dakui Gan, Lu Mo, Shaobo Dai, Weixing Liang, Lei Yang, Yufei Xu, Midie Li, Jing Zheng, Peiyong Li, Xinxiang Li, Yan Wang, Ziliang |
author_facet | Li, Qingguo Sun, Huizhen Luo, Dakui Gan, Lu Mo, Shaobo Dai, Weixing Liang, Lei Yang, Yufei Xu, Midie Li, Jing Zheng, Peiyong Li, Xinxiang Li, Yan Wang, Ziliang |
author_sort | Li, Qingguo |
collection | PubMed |
description | BACKGROUND: Resistance to oxaliplatin is a major obstacle for the management of locally advanced and metastatic colon cancer (CC). Although long noncoding RNAs (lncRNAs) play key roles in CC, the relationships between lncRNAs and resistance to oxaliplatin have been poorly understood yet. METHODS: Chemo-sensitive and chemo-resistant organoids were established from colon cancer tissues of the oxaliplatin-sensitive or -resistant patients. Analysis of the patient cohort indicated that lnc-RP11-536 K7.3 had a potential oncogenic role in CC. Further, a series of functional in vitro and in vivo experiments were conducted to assess the effects of lnc-RP11-536 K7.3 on CC proliferation, glycolysis, and angiogenesis. RNA pull-down assay, luciferase reporter and fluorescent in situ hybridization assays were used to confirm the interactions between lnc-RP11-536 K7.3, SOX2 and their downstream target HIF-1α. RESULTS: In this study, we identified a novel lncRNA, lnc-RP11-536 K7.3, was associated with resistance to oxaliplatin and predicted a poor survival. Knockout of lnc-RP11-536 K7.3 inhibited the proliferation, glycolysis, and angiogenesis, whereas enhanced chemosensitivity in chemo-resistant organoids and CC cells both in vitro and in vivo. Furthermore, we found that lnc-RP11-536 K7.3 recruited SOX2 to transcriptionally activate USP7 mRNA expression. The accumulative USP7 resulted in deubiquitylation and stabilization of HIF-1α, thereby facilitating resistance to oxaliplatin. CONCLUSION: In conclusion, our findings indicated that lnc-RP11-536 K7.3 could promote proliferation, glycolysis, angiogenesis, and chemo-resistance in CC by SOX2/USP7/HIF-1α signaling axis. This revealed a new insight into how lncRNA could regulate chemosensitivity and provide a potential therapeutic target for reversing resistance to oxaliplatin in the management of CC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02143-x. |
format | Online Article Text |
id | pubmed-8570024 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85700242021-11-08 Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids Li, Qingguo Sun, Huizhen Luo, Dakui Gan, Lu Mo, Shaobo Dai, Weixing Liang, Lei Yang, Yufei Xu, Midie Li, Jing Zheng, Peiyong Li, Xinxiang Li, Yan Wang, Ziliang J Exp Clin Cancer Res Research BACKGROUND: Resistance to oxaliplatin is a major obstacle for the management of locally advanced and metastatic colon cancer (CC). Although long noncoding RNAs (lncRNAs) play key roles in CC, the relationships between lncRNAs and resistance to oxaliplatin have been poorly understood yet. METHODS: Chemo-sensitive and chemo-resistant organoids were established from colon cancer tissues of the oxaliplatin-sensitive or -resistant patients. Analysis of the patient cohort indicated that lnc-RP11-536 K7.3 had a potential oncogenic role in CC. Further, a series of functional in vitro and in vivo experiments were conducted to assess the effects of lnc-RP11-536 K7.3 on CC proliferation, glycolysis, and angiogenesis. RNA pull-down assay, luciferase reporter and fluorescent in situ hybridization assays were used to confirm the interactions between lnc-RP11-536 K7.3, SOX2 and their downstream target HIF-1α. RESULTS: In this study, we identified a novel lncRNA, lnc-RP11-536 K7.3, was associated with resistance to oxaliplatin and predicted a poor survival. Knockout of lnc-RP11-536 K7.3 inhibited the proliferation, glycolysis, and angiogenesis, whereas enhanced chemosensitivity in chemo-resistant organoids and CC cells both in vitro and in vivo. Furthermore, we found that lnc-RP11-536 K7.3 recruited SOX2 to transcriptionally activate USP7 mRNA expression. The accumulative USP7 resulted in deubiquitylation and stabilization of HIF-1α, thereby facilitating resistance to oxaliplatin. CONCLUSION: In conclusion, our findings indicated that lnc-RP11-536 K7.3 could promote proliferation, glycolysis, angiogenesis, and chemo-resistance in CC by SOX2/USP7/HIF-1α signaling axis. This revealed a new insight into how lncRNA could regulate chemosensitivity and provide a potential therapeutic target for reversing resistance to oxaliplatin in the management of CC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02143-x. BioMed Central 2021-11-05 /pmc/articles/PMC8570024/ /pubmed/34740372 http://dx.doi.org/10.1186/s13046-021-02143-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Li, Qingguo Sun, Huizhen Luo, Dakui Gan, Lu Mo, Shaobo Dai, Weixing Liang, Lei Yang, Yufei Xu, Midie Li, Jing Zheng, Peiyong Li, Xinxiang Li, Yan Wang, Ziliang Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids |
title | Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids |
title_full | Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids |
title_fullStr | Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids |
title_full_unstemmed | Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids |
title_short | Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids |
title_sort | lnc-rp11-536 k7.3/sox2/hif-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570024/ https://www.ncbi.nlm.nih.gov/pubmed/34740372 http://dx.doi.org/10.1186/s13046-021-02143-x |
work_keys_str_mv | AT liqingguo lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT sunhuizhen lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT luodakui lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT ganlu lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT moshaobo lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT daiweixing lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT lianglei lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT yangyufei lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT xumidie lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT lijing lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT zhengpeiyong lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT lixinxiang lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT liyan lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids AT wangziliang lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids |